Orion Nutraceuticals Delisting from the CSE
(TheNewswire)
Vancouver, British Columbia – July30, 2025 – TheNewswire - Orion NutraceuticalsInc. , (CSE: ORI ) (the “ Company ” or“ Orion ”) announces that it hasreceived approval from the Canadian Securities Exchange (the“ CSE ”) to voluntarily delist its common shares from the CSE.The Company expects the delisting to become effective at the close oftrading on July 30, 2025.
Following the delisting, the Company will remain areporting issuer in the provinces of British Columbia and Ontario andwill continue to comply with its continuous disclosure obligationsunder applicable securities laws in those jurisdictions.
The decision to delist from the CSE was made aftercareful consideration of the Company's current operational needs,trading volumes, and the costs associated with maintaining a listing.The Company believes that the delisting is in the best interests ofthe Company and its shareholders.
Shareholders are encouraged to consult with theirinvestment advisors regarding the implications of thedelisting.
About Orion NutraceuticalsInc.
Orion Nutraceuticals Inc. is actively evaluatingpotential investment and acquisition opportunities.
ON BEHALF OF THE BOARD
Guy Bourgeois, Director
Tel: ( 604) 687-2038
The CSE hasneither approved nor disapproved the contents of this news release.Neither the CSE nor its Market Regulator (as that term is defined inthe policies of the CSE) accepts responsibility for the adequacy oraccuracy of this news release.
Forward-LookingStatements
This news release contains"forward-looking information" and "forward-lookingstatements" (collectively, “forward-looking statements”)within the meaning of applicable securities laws, including statementsregarding the Company’s intention to delist from CSE, theanticipated benefits of the Delisting, the Company’s ongoingobligations as a reporting issuer, and the potential impact onshareholders and trading liquidity. Forward-looking statements arebased on the opinions, assumptions and estimates of management as ofthe date they are made and are subject to various known and unknownrisks and uncertainties.
These risks include, but are notlimited to, changes in market conditions, regulatory developments, theCompany’s ability to maintain compliance with applicable laws, andother factors that may cause actual outcomes to differ materially fromthose expressed or implied by such forward-looking statements.
Readers are cautioned not to placeundue reliance on forward-looking statements. Except as required byapplicable law, the Company undertakes no obligation to update orrevise any forward-looking statements, whether as a result of newinformation, future events or otherwise.
Copyright (c) 2025 TheNewswire - All rights reserved.
NASDAQ: ORONF
ORONF Trading
0.0% G/L:
$0.2862 Last:
400 Volume:
$0.2862 Open:



